3.3.12 make, or permit any subsidiary to make, any loan or advance to the any subsidiary or other corporation, partnership, or other entity unless it is wholly owned by the Company;
3.3.13 increase the authorized number of shares of capital stock available for issuance to employees or directors of, or consultants or advisors of the Corporation or any of its subsidiaries pursuant to the Corporation’s equity incentive plan or a similar plan, agreement or arrangement; or
3.3.14 cause or permit any of its subsidiaries to, without approval of the Board of Directors, including the approval of a majority of the Series A Directors, sell, issue, sponsor, create or distribute any digital tokens, cryptocurrency or other blockchain-based assets (collectively, “Tokens”), including through a pre-sale, initial coin offering, token distribution event or crowdfunding, or through the issuance of any instrument convertible into or exchangeable for Tokens.
3.4 Series B Preferred Stock Protective Provisions. At any time when at least 8,230,933 shares of Series B Preferred Stock are outstanding, the Corporation shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or the Certificate of Incorporation) the written consent or affirmative vote of the Series B Requisite Holders, given in writing or by vote at a meeting, consenting or voting (as the case may be) separately as a class, and any such act or transaction entered into without such consent or vote shall be null and void ab initio, and of no force or effect:
3.4.1 liquidate, dissolve or wind-up the business and affairs of the Corporation, effect a Deemed Liquidation Event, or consent to any of the foregoing prior to the first anniversary of the Series B Original Issue Date that would result in a payment to the holders of shares of Series B Preferred Stock of aggregate consideration payable per share in such Deemed Liquidation Event in an amount less than the aggregate Series B Original Issue Price;
3.4.2 amend, alter or repeal any provision of the Certificate of Incorporation or Bylaws of the Corporation in a manner that adversely affects the rights, powers, preferences, or privileges of the shares of Series B Preferred Stock; or
3.4.3 increase or decrease the authorized number of shares of Series B Preferred Stock.
3.5 Series A Preferred Stock Protective Provisions. At any time when at least 10,000,000 shares of Series A Preferred Stock (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series A Preferred Stock) are outstanding, the Corporation shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or the Certificate of Incorporation) the written consent or affirmative vote of the Series A Requisite Holders (as defined below), given in writing or by vote at a meeting, consenting or voting (as the case may be) separately as a class, and any such act or transaction entered into without such consent or vote shall be null and void ab initio, and of no force or effect:
3.5.1 amend, alter or repeal any provision of the Certificate of Incorporation or Bylaws of the Corporation in a manner that adversely affects the rights, preferences, powers and privileges of the holders of shares of Series A Preferred Stock; or
10